The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial

St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists

(2015) M. Ignatiadis et al.   ANNALS OF ONCOLOGY

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

(2015) Thomas J. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast cancer in China

(2014) Lei Fan et al.   LANCET ONCOLOGY

Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

(2013) Christopher R. Flowers et al.   JOURNAL OF CLINICAL ONCOLOGY

Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis

(2011) Katy L Cooper et al.   BMC CANCER

Moxibustion for cancer care: a systematic review and meta-analysis

(2010) Myeong Soo Lee et al.   BMC CANCER

A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (standard) for women with early breast cancer

(2009) R L Jones et al.   BRITISH JOURNAL OF CANCER

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast Cancer

(2008) Chau Dang et al.   JOURNAL OF CLINICAL ONCOLOGY

Sample Size Calculations in Clinical Research

(2008) Ian White   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY